Sort
10,766 grants matching “checkpoint inhibitor”
Serial Ultrasound to Detect Early Response to Immunotherapy in Metastatic RCC
$212,197Alice Chen Fan · Stanford University · R21 · FY2023 · CA
RNF125 controls melanoma response to B-RAF inhibitor and immune checkpoint therapy
$212,063Hyungsoo Kim · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2016 · CA
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
$212,063Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2018 · CA
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$212,016Nicholas C Denko · Ohio State University · R01 · FY2023 · CA
DNA MISMATCH REPAIR IN FDURD INDUCED CYTOTOXICITY
$211,905Case Western Reserve University · R01 · FY2002 · CA
Admin-Core-001
$211,875Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$211,875Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.
$211,464Tyler Eugene Miller · Case Western Reserve University · K08 · FY2024 · CA
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.
$211,464Tyler Eugene Miller · Case Western Reserve University · K08 · FY2025 · CA
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.
$211,464Tyler Eugene Miller · Massachusetts General Hospital · K08 · FY2023 · CA
Immunological manipulation of resistance to molecularly targeted inhibitors
$211,410Mary J Turk · Dartmouth College · R21 · FY2017 · CA
Microbiota and the anti-tumor action of anti-CD47 immunomodulation.
$211,410Ralph R Weichselbaum · University Of Chicago · R21 · FY2020 · CA
cGAS-STING and therapeutic immune responses in neuroblastoma
$211,259Adam J Wolpaw · Children'S Hosp Of Philadelphia · K08 · FY2022 · CA
cGAS-STING and therapeutic immune responses in neuroblastoma
$211,259Adam J Wolpaw · Children'S Hosp Of Philadelphia · K08 · FY2025 · CA
cGAS-STING and therapeutic immune responses in neuroblastoma
$211,259Adam J Wolpaw · Children'S Hosp Of Philadelphia · K08 · FY2023 · CA
cGAS-STING and therapeutic immune responses in neuroblastoma
$211,259Adam J Wolpaw · Children'S Hosp Of Philadelphia · K08 · FY2024 · CA
Understanding and Overcoming Immunotherapy Resistance in Pediatric High-Grade Glioma
$211,250Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · NS
Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer
$210,978Paolo Serafini · University Of Miami School Of Medicine · R21 · FY2022 · CA
Tumor-Immune Interactions and Cisplatin Resistance in Bladder Cancer
$210,973Filipe De Carvalho · Brigham And Women'S Hospital · K08 · FY2025 · CA
Tumor-Immune Interactions and Cisplatin Resistance in Bladder Cancer
$210,973Filipe De Carvalho · Brigham And Women'S Hospital · K08 · FY2024 · CA
GENETICS OF CELL CYCLE &DNA DAMAGE REGULATION IN YEAST
$210,880Baylor College Of Medicine · R01 · FY2002 · GM
Novel oncolytic virotherapy for brain tumors
$210,845Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2017 · NS
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer
$210,627Alexandre Gaspar Maia · Mayo Clinic Rochester · P50 · FY2025 · CA
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer
$210,627Alexandre Gaspar Maia · Mayo Clinic Rochester · P50 · FY2025 · CA
Regulation of Replication Checkpoint by Proteolysis
$210,426Hui Zhang · Nevada Cancer Institute · R01 · FY2007 · CA